心脏外科手术后血管性休克中的Oxiris过疗法:单中心回顾性研究
Oskar Juvakka1, Kristina Svennerholm2, Lukas Lannemyr1
1Department of Anesthesiology and Intensive Care Medicine, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiothoracic Anaesthesia, Sahlgrenska University Hospital, Gothenburg, Sweden.
Journal of cardiothoracic and vascular anesthesia
|February 22, 2026
概括
使用Oxiris过器的连续置换疗法 (CRRT) 在患有血管的心脏手术患者中显著降低了血管活性内支持. 这种吸血疗法通过降低血管压缩剂的要求来改善血液动力稳定性.
科学领域:
- 心血管外科心血管外科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
背景情况:
- 血管是心脏手术后的严重并发症,通常与内毒素和细胞因子释放有关.
- 血管活性无otropic 支持对于管理血管至关重要,但具有风险.
- 持续置换疗法 (CRRT) 用于管理并发症,但其在改善血液动力学稳定性方面的作用在此方面仍在调查中.
研究的目的:
- 在CRRT期间评估Oxiris血液吸收过器在心脏手术后血管患者改善血液动力稳定性的有效性.
- 为了比较Oxiris和标准CRRT过器之间的血管活性无otropic评分 (VIS) 的降低.
主要方法:
- 在心胸重症监护室进行了回顾性单中心研究.
- 包括患有血管的患者 (心脏指数≥2.2 L/min/m2和上腺素≥0.60 μg/kg/min) 需要在心脏手术后24小时内进行CRRT.
- 与标准CRRT过器 (对照组) 进行比较的Oxiris吸血过器.
主要成果:
- 分析了58名患者;Oxiris组的VIS基线较高.
- 与对照组相比,Oxiris组在48小时内显示出显著更大的VIS减少 (平均差异-18.9,p=0.045).
- 在Oxiris组中,降低上腺素剂量是VIS减少的主要驱动因素 (平均差异-0.19μg/kg/min,p=0.019).
结论:
- 在CRRT期间的Oxiris过疗法与心脏手术后血管的血管活性异型支持需求显著减少有关.
- 这项研究表明,Oxiris血吸可能是治疗血管的有益辅助疗法.
- 在其他血液动力学参数,液体平衡,ICU住院或30天死亡率方面没有发现显著差异.
更多相关视频
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
671
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
671


